Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/19701
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCalogeropoulou, T.en
dc.contributor.authorAvlonitis, N.en
dc.contributor.authorMinas, V.en
dc.contributor.authorAlexi, X.en
dc.contributor.authorPantzou, A.en
dc.contributor.authorCharalampopoulos, I.en
dc.contributor.authorZervou, M.en
dc.contributor.authorVergou, V.en
dc.contributor.authorKatsanou, E. S.en
dc.contributor.authorLazaridis, I.en
dc.contributor.authorAlexis, M. N.en
dc.contributor.authorGravanis, A.en
dc.date.accessioned2015-11-24T19:01:31Z-
dc.date.available2015-11-24T19:01:31Z-
dc.identifier.issn1520-4804-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/19701-
dc.rightsDefault Licence-
dc.subjectAnimalsen
dc.subjectApoptosis/*drug effectsen
dc.subjectCell Line, Tumoren
dc.subjectCell Proliferation/drug effectsen
dc.subjectDehydroepiandrosterone/adverse effects/*analogs & derivatives/*chemicalen
dc.subjectsynthesis/pharmacologyen
dc.subjectEstrogen Receptor alpha/agonists/biosynthesisen
dc.subjectEstrogen Receptor beta/agonists/biosynthesisen
dc.subjectHumansen
dc.subjectModels, Molecularen
dc.subjectMolecular Conformationen
dc.subjectNeurons/cytology/drug effectsen
dc.subjectNeuroprotective Agents/adverse effects/*chemical synthesis/pharmacologyen
dc.subjectRatsen
dc.subjectStructure-Activity Relationshipen
dc.titleNovel dehydroepiandrosterone derivatives with antiapoptotic, neuroprotective activityen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primary10.1021/jm900468p-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/19845386-
heal.identifier.secondaryhttp://pubs.acs.org/doi/pdfplus/10.1021/jm900468p-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2009-
heal.abstractDHEA analogues with modifications at positions C3 or C17 were synthesized and evaluated for neuroprotective activity against the neural-crest-derived PC12 cell model of serum deprivation-induced apoptosis. The most potent compounds were the spiro-epoxy derivatives 17beta-spiro[5-androstene-17,2'-oxiran]-3beta-ol (20), (20S)-3beta,21-dihydroxy-17beta,20-epoxy-5-pregnene (23), and (20R)-3beta,21-dihydroxy-17alpha,20-epoxy-5-pregnene (27) with IC(50) values of 0.19 +/- 0.01, 99.0 +/- 4.6, and 6.4 +/- 0.3 nM, respectively. Analogues 20, 23, and 27, up to the micromolar range of concentrations, were unable to activate estrogen receptor alpha and beta (ERalpha and ERbeta) or to interfere with ER-dependent gene expression significantly. In addition, they were unable to stimulate the growth of Ishikawa, MCF-7, and LNCaP cells. Our results suggest that the spiro-epoxyneurosteroid derivatives 20, 23, and 27 may prove to be lead molecules for the synthesis of novel neuroprotective agents.en
heal.journalNameJ Med Chemen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Calogeropoulou-2009-Novel dehydroepiandr.pdf1.53 MBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons